Product Information
DEXAMETHASONE 20 MG/5 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2014 per ML under NDC 00641614610. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641614610
Classification
Generic
Dosage Form
INJECTION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE
Effective Date
7/22/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA084282FDA Approved
Before 1982
TE Code
AP
On Market Since
7/15/1975
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has been published 42 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2014 per ML |
|---|---|
| All-time high | $0.2050 (Apr 15, 2026) |
| All-time low | $0.2014 (Jul 22, 2026) |
| 52-week high | $0.2050 |
| 52-week low | $0.2014 |
| Median price | $0.2041 |
| Average price | $0.2034 |
| Largest weekly change | -0.7% (May 20, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone Sodium Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 20 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 20 MG/5 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2014 per ML (NDC 00641614610), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 20 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 20 MG/5 ML VIAL?
Since Dec 17, 2025, the NADAC for DEXAMETHASONE 20 MG/5 ML VIAL has ranged from a low of $0.2014 (Jul 22, 2026) to a high of $0.2050 (Apr 15, 2026), with a median of $0.2041 per ML.
Are there cheaper alternatives to DEXAMETHASONE 20 MG/5 ML VIAL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXAMETHASONE 20 MG/5 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXAMETHASONE 20 MG/5 ML VIAL?
DEXAMETHASONE 20 MG/5 ML VIAL (NDC 00641614610) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.